about
Interaction of the HIV-1 intasome with transportin 3 protein (TNPO3 or TRN-SR2)HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiencyHuman MX2 is an interferon-induced post-entry inhibitor of HIV-1 infectionMX2 is an interferon-induced inhibitor of HIV-1 infectionHIV type 1 Gag as a target for antiviral therapyCellular and viral determinants of retroviral nuclear entryHIV-1 capsid: the multifaceted key player in HIV-1 infectionMisdelivery at the Nuclear Pore Complex-Stopping a Virus Dead in Its TracksA model for cofactor use during HIV-1 reverse transcription and nuclear entryCellular self-defense: how cell-autonomous immunity protects against pathogensVirus strategies for passing the nuclear envelope barrierHIV-1 reverse transcriptionNuclear trafficking of retroviral RNAs and Gag proteins during late steps of replicationThe Road Less Traveled: HIV's Use of Alternative Routes through Cellular PathwaysDynamics and restriction of murine leukemia virus cores in mitotic and interphase cellsKIF5B and Nup358 Cooperatively Mediate the Nuclear Import of HIV-1 during InfectionCyclophilin A stabilizes the HIV-1 capsid through a novel non-canonical binding site.CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 ReplicationGain-of-Sensitivity Mutations in a Trim5-Resistant Primary Isolate of Pathogenic SIV Identify Two Independent Conserved Determinants of Trim5α SpecificityDiscovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid ComplexesHIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358HIV-1 evades innate immune recognition through specific cofactor recruitmentStructural basis for nuclear import of splicing factors by human Transportin 3Gene expression analysis of a panel of cell lines that differentially restrict HIV-1 CA mutants infection in a cyclophilin a-dependent mannerLv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to IntegrationRetroviral DNA IntegrationPrimate TRIM5 proteins form hexagonal nets on HIV-1 capsids.Structural basis of HIV-1 capsid recognition by PF74 and CPSF6.Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration.Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integrationSuperresolution imaging of HIV in infected cells with FlAsH-PALMHIV-1 uncoating is facilitated by dynein and kinesin 1HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration.Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain.Structural basis for spumavirus GAG tethering to chromatinMicrobial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex.HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2Interactions between HIV-1 and the cell-autonomous innate immune system.
P2860
Q24295223-53636761-87F5-45BE-8114-38EBC09FA69FQ24300016-3D249C5E-8720-4E63-A5B4-B0999EE6D830Q24336824-454BBCE7-AD30-401D-8F03-3D3C2C464B91Q24338311-3079967B-3D9D-4F09-89AB-934F3376028EQ24614498-AE7B1F05-34B2-4D13-8AC6-608328E5E89CQ26778299-6DB112E3-5E3A-424A-802B-EC4720D37C65Q26801145-C93A197E-C11F-4056-9A1C-9CE38DFACF6BQ26801484-02117607-2A93-4FF8-A1EA-0A114B0BDC34Q26859218-B69C64F6-D5A2-4AEF-9A8B-CF2FD4365120Q26864521-89F34D42-D74C-42FE-8B5B-060BA8971BD1Q26866395-B9D47BDC-D3D8-45ED-9F25-DF609D5BF5C6Q27023387-C014278A-B2F3-499B-9716-B0E9B3A6198DQ27026209-CB0DE2D9-D725-4E00-A572-3101C42CB31BQ27027607-4374A5E8-8732-44DB-AF99-1258E9ADE48FQ27303013-90B46A65-EF03-4B62-B6EB-0FDEA916DDE5Q27313449-D92EAD89-1991-449C-B023-C5B906CBBC1DQ27332017-65B4A02E-781C-4CBF-B7E0-68C9E6E25066Q27672646-BD98FD14-D802-45DB-AB84-0CB6C2D13BACQ27678143-C9639FD9-76DF-4875-A7B6-D6646FE89CF4Q27678859-A8E4DDBA-393A-4A18-975B-A6ECA3237703Q27679304-82AC5F5E-036E-458A-8C77-42163C133440Q27680544-3DC64B94-2B3E-4CBC-90A0-84ADACDD3BE1Q27681422-17EB6B97-4D35-4122-8221-D8214CB4DF9FQ28541423-7ADE4A23-4A86-407A-B3F6-CC9ED185EBE2Q28546614-B2BC887B-5F56-4354-AF55-2AE4F3708A17Q28596842-D9BBBE86-4ADF-4017-BC68-CD7EA909DADFQ30276687-0526A326-5049-47DD-A9C7-83BA5B2FC9D0Q30301100-4837925C-4FCA-4395-9124-828EC5DE9E51Q30400372-1F8989FB-3537-4CB7-AC82-80BB1BF2F2C1Q30406846-D8DD57DF-CDB4-4545-9E78-9B889DB5A7FBQ30452981-BB22D77B-4D40-459D-8A61-1481FF981663Q30514336-B1C27BE3-196A-4D7E-BAF2-568D063BD15FQ30603540-E6CCE3BC-F01E-4773-9F35-E6EF9F685B8DQ30634144-C96443DA-8DA3-4588-B997-2D04ADD7DFACQ31103609-B0B7D9AB-0D36-4D82-AC01-6B4FF96D8522Q33601292-823152B2-11EF-42AE-BFA3-284057ADE736Q33737883-8C913F07-258A-4B78-9605-0CD8BE51F37EQ33753929-9E6646D6-960D-4E32-9CB2-6B960CAF2598Q33851502-CB09BAE9-B9BB-4184-9203-530A938F8D13Q33895123-FD71939F-E182-46BE-8AAE-60F980C10C16
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Flexible use of nuclear import pathways by HIV-1.
@ast
Flexible use of nuclear import pathways by HIV-1.
@en
type
label
Flexible use of nuclear import pathways by HIV-1.
@ast
Flexible use of nuclear import pathways by HIV-1.
@en
prefLabel
Flexible use of nuclear import pathways by HIV-1.
@ast
Flexible use of nuclear import pathways by HIV-1.
@en
P2093
P2860
P1433
P1476
Flexible use of nuclear import pathways by HIV-1.
@en
P2093
Alan Engelman
Alok Mulky
Dan R Littman
Derya Unutmaz
Ichiro Taniuchi
Ilker Oztop
Joerg G Baumann
John G Julias
John M Coffin
Kenneth Shelton
P2860
P304
P356
10.1016/J.CHOM.2010.02.007
P577
2010-03-01T00:00:00Z